Prof. Kannan Sridharan

Professor of Pharmacology and Therapeutics

Department of Pharmacology and Therapeutics

College of Medicine and Health Sciences

kannans@agu.edu.bh
البريد الإلكتروني
السيرة الذاتية تحميل
الباحث العلمي (جوجل)
Go To Page
 
مختصر السيرة الذاتية▼

     Dr. Kannan Sridharan is a Professor of Pharmacology and Therapeutics at the College of Medicine and Health Sciences, Arabian Gulf University, Bahrain. Dr. Sridharan has made significant contributions to pharmacovigilance, systematic reviews, and network meta-analyses, with a research focus spanning clinical pharmacology, neonatology, and therapeutics. His work is widely published in high-impact journals, including Nature and British Journal of Clinical Pharmacology, and he is an editorial board member for prominent Clinical pharmacology journal.  

التعليم الأكاديمي▼
  • Doctorate in Medicine, DM Clinical Pharmacology, Maharastra University of Health Sciences, India, 2012. 
  • Doctor in Medicine -MD Pharmacology, TN Dr. MGR Medical University, India, 2009. 
  • MBBS, TN Dr. MGR Medical University, India, 2004. 
الإهتمامات البحثية▼
  • Pharmacokinetics & Pharmacodynamics 
  • Pharmacogenetics & Pharmacovigilance  
  • Systematic reviews & and network meta-analyses  
البحوث المختارة▼
  1. Sridharan K, Ansari EA, Mulubwa M, Raju AP, Madhoob AA, Jufairi MA, Hubail Z, Marzooq RA, Hasan SJR, Mallaysamy S. Population pharmacokinetic-pharmacodynamic modeling of acetaminophen in preterm neonates with hemodynamically significant patent ductus arteriosus. Eur J Pharm Sci. 2021 Dec 1;167:106023. 
  2. Sridharan K, Al Banna R, Malalla Z, Husain A, Sater M, Jassim G, Otoom S. Influence of CYP2C9, VKORC1, and CYP4F2 polymorphisms on the pharmacodynamic parameters of warfarin: a cross-sectional study. Pharmacol Rep. 2021 Oct;73(5):1405-1417.  
  3. Sridharan K, G Sivaramakrishnan. A pharmacovigilance study assessing risk of angioedema with angiotensin receptor blockers using the US FDA Adverse Event Reporting System. Expert Opinion on Drug Safety. June 2024 
  4. Sridharan K, G Sivaramakrishnan. Risk of limb amputation and bone fractures with sodium glucose cotransporter-2 inhibitors: a network meta-analysis and meta-regression. Expert Opinion on Drug Safety. July 2024 
  5. Sridharan K, Sequeira RP. Evaluation of artificial intelligence-generated drug therapy communication skill competencies in medical education. British Journal of Clinical Pharmacology. July 2024